Cargando…

Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators

Vaccinia virus (VACV)-derived vectors are popular candidates for vaccination against diseases such as HIV-1, malaria and tuberculosis. However, their genomes encode a multitude of proteins with immunomodulatory functions, several of which reduce the immunogenicity of these vectors. Hitherto only lim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sumner, Rebecca P., Ren, Hongwei, Ferguson, Brian J., Smith, Geoffrey L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022402/ https://www.ncbi.nlm.nih.gov/pubmed/27544585 http://dx.doi.org/10.1016/j.vaccine.2016.08.002

Ejemplares similares

Deletion of immunomodulator C6 from vaccinia virus strain Western Reserve enhances virus immunogenicity and vaccine efficacy
por: Sumner, Rebecca P., et al.
Publicado: (2013)

Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory
por: Albarnaz, Jonas D., et al.
Publicado: (2018)

Enhancement of CD8(+) T-cell memory by removal of a vaccinia virus nuclear factor-κB inhibitor
por: Ren, Hongwei, et al.
Publicado: (2015)

Generation of an Attenuated Tiantan Vaccinia Virus Strain by Deletion of Multiple Genes
por: Li, Yiquan, et al.
Publicado: (2017)

DNA-PK Is Targeted by Multiple Vaccinia Virus Proteins to Inhibit DNA Sensing
por: Scutts, Simon R., et al.
Publicado: (2018)

Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence
por: Ferguson, Brian J., et al.
Publicado: (2013)

Effect of the ati Gene Deletion on the Pathogenicity and Immunogenicity of the Vaccinia Virus
por: Yakubitskiy, S. N., et al.
Publicado: (2023)

Multiple Bcl-2 family immunomodulators from vaccinia virus regulate MAPK/AP-1 activation
por: Torres, Alice A., et al.
Publicado: (2016)

Vaccinia virus virulence factor N1 can be ubiquitylated on multiple lysine residues
por: Maluquer de Motes, Carlos, et al.
Publicado: (2014)

Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence
por: Ember, Stuart W. J., et al.
Publicado: (2012)

Enhancing the Immunogenicity of Vaccinia Virus
por: Shchelkunov, Sergei N., et al.
Publicado: (2022)

Genes that Control Vaccinia Virus Immunogenicity
por: Shchelkunov, S. N., et al.
Publicado: (2020)

Attenuation of Vaccinia Virus
por: Yakubitskiy, S. N., et al.
Publicado: (2015)

Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve Immunogenicity
por: Alharbi, Naif Khalaf, et al.
Publicado: (2015)

Enhanced Efficacy of Vaccination With Vaccinia Virus in Old vs. Young Mice
por: Shmeleva, Evgeniya V., et al.
Publicado: (2019)

Vaccinia Virus Protein C6 Is a Virulence Factor that Binds TBK-1 Adaptor Proteins and Inhibits Activation of IRF3 and IRF7
por: Unterholzner, Leonie, et al.
Publicado: (2011)

Vaccinia Virus Inhibits NF-κB-Dependent Gene Expression Downstream of p65 Translocation
por: Sumner, Rebecca P., et al.
Publicado: (2014)

Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B
por: Pérez, Patricia, et al.
Publicado: (2020)

An increase in glycoprotein concentration on extracellular virions dramatically alters vaccinia virus infectivity and pathogenesis without impacting immunogenicity
por: Monticelli, Stephanie R., et al.
Publicado: (2021)

Effect of the Deletion of Genes Encoding Proteins of the Extracellular Virion Form of Vaccinia Virus on Vaccine Immunogenicity and Protective Effectiveness in the Mouse Model
por: Meseda, Clement A., et al.
Publicado: (2013)

Vaccinia Virus Protein C6 Inhibits Type I IFN Signalling in the Nucleus and Binds to the Transactivation Domain of STAT2
por: Stuart, Jennifer H., et al.
Publicado: (2016)

Leaky scanning translation generates a second A49 protein that contributes to vaccinia virus virulence
por: Neidel, Sarah, et al.
Publicado: (2020)

Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy
por: Pelin, Adrian, et al.
Publicado: (2019)

Suppression of innate immunity by the vaccinia virus protein N1 promotes skin microbiota expansion and increased immune infiltration following vaccination
por: Shmeleva, Evgeniya V., et al.
Publicado: (2022)

Robust Intrapulmonary CD8 T Cell Responses and Protection with an Attenuated N1L Deleted Vaccinia Virus
por: Mathew, Anuja, et al.
Publicado: (2008)

Transcriptional reprogramming of natural killer cells by vaccinia virus shows both distinct and conserved features with mCMV
por: Depierreux, Delphine M., et al.
Publicado: (2023)

Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection
por: Benfield, Camilla T. O., et al.
Publicado: (2013)

Zoonotic vaccinia virus strains belonging to different genetic clades exhibit immunomodulation abilities that are proportional to their virulence
por: Lourenço, Karine Lima, et al.
Publicado: (2021)

Vaccinia Virus Immunomodulator A46: A Lipid and Protein-Binding Scaffold for Sequestering Host TIR-Domain Proteins
por: Fedosyuk, Sofiya, et al.
Publicado: (2016)

Vaccinia virus BTB-Kelch proteins C2 and F3 inhibit NF-κB activation
por: Zhang, Rui-Yao, et al.
Publicado: (2022)

NF-κB activation is a turn on for vaccinia virus phosphoprotein A49 to turn off NF-κB activation
por: Neidel, Sarah, et al.
Publicado: (2019)

Pathogeneses of respiratory infections with virulent and attenuated vaccinia viruses
por: Hayasaka, Daisuke, et al.
Publicado: (2007)

Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity
por: Hirvinen, Mari, et al.
Publicado: (2016)

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo
por: Gorry, Paul R, et al.
Publicado: (2007)

Analysis of the anti-apoptotic activity of four vaccinia virus proteins demonstrates that B13 is the most potent inhibitor in isolation and during viral infection
por: Veyer, David L., et al.
Publicado: (2014)

Inhibition of Translation Initiation by Protein 169: A Vaccinia Virus Strategy to Suppress Innate and Adaptive Immunity and Alter Virus Virulence
por: Strnadova, Pavla, et al.
Publicado: (2015)

Deletion of C7L and K1L Genes Leads to Significantly Decreased Virulence of Recombinant Vaccinia Virus TianTan
por: Liu, Zheng, et al.
Publicado: (2013)

Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9
por: Deng, Lili, et al.
Publicado: (2017)

Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development
por: Ho, Tiffany Y., et al.
Publicado: (2021)

Comprehensive evaluation of the safety and immunogenicity of a gene-deleted variant pseudorabies virus attenuated vaccine
por: Li, Ling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t2jirk2vdf3tt8c0mgmsv9m4g9